Zhang C, Liang H, Qin Y, Tan X, et al. A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. PLoS One 2026;21:e0341154.
PMID: 41570001